Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary lymphangiomyomatosis.

W Dishner, E M Cordasco, J Blackburn

    Chest
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Higher versus lower mean arterial blood pressure after cardiac arrest and resuscitation (MAP-CARE): A protocol for a randomized clinical trial.

    Acta anaesthesiologica Scandinavica·2025
    Same author

    Fever management with or without a temperature control device after out-of-hospital cardiac arrest and resuscitation (TEMP-CARE): A study protocol for a randomized clinical trial.

    Acta anaesthesiologica Scandinavica·2025
    Same author

    Sedation, temperature and pressure after cardiac arrest and resuscitation-The STEPCARE trial: A statistical analysis plan.

    Acta anaesthesiologica Scandinavica·2025
    Same author

    Blood pressure management for caesarean delivery under spinal anaesthesia: a UK multi-centre audit (2023).

    International journal of obstetric anesthesia·2025
    Same author

    Continuous deep sedation versus minimal sedation after cardiac arrest and resuscitation (SED-CARE): A protocol for a randomized clinical trial.

    Acta anaesthesiologica Scandinavica·2025
    Same author

    [Use of antimicrobials in a mother-child university hospital center in Canada: An observational study].

    Annales pharmaceutiques francaises·2023

    Lymphangiomyomatosis (LAM) is a rare disease. Progesterone therapy showed clinical improvement in one LAM patient, even with negative sex steroid receptors, suggesting new therapeutic possibilities.

    Area of Science:

    • Pulmonary Medicine
    • Oncology
    • Rare Diseases

    Background:

    • Lymphangiomyomatosis (LAM) is a rare, progressive lung disease characterized by abnormal smooth muscle growth.
    • It primarily affects women and is associated with mutations in the TSC1 or TSC2 genes.
    • Distinctive clinical and histopathologic features define LAM.

    Observation:

    • This report details two additional cases of lymphangiomyomatosis.
    • One patient experienced clinical improvement following progesterone therapy.
    • Notably, this patient had negative sex steroid receptor analysis.

    Findings:

    • Progesterone therapy demonstrated efficacy in a lymphangiomyomatosis case.
    • Clinical improvement occurred despite the absence of detectable sex steroid receptors.

    Related Experiment Videos

  • This challenges previous assumptions regarding treatment response mechanisms.

    • Implications:

    • These findings suggest novel therapeutic strategies for lymphangiomyomatosis.
    • Further research into progesterone's mechanism in LAM is warranted.
    • This could lead to improved management for patients with this rare condition.